UCPH-101 is primarily used in neuroscience research as a selective inhibitor of the glutamate transporter EAAT1 (excitatory amino acid transporter 1). It is particularly valuable in studying the role of glutamate transport in the central nervous system, as it helps researchers understand the mechanisms underlying conditions like neurodegenerative diseases, epilepsy, and stroke. By blocking EAAT1, UCPH-101 allows scientists to investigate how disruptions in glutamate uptake affect neuronal excitability and synaptic transmission. This compound is also utilized in experimental models to explore potential therapeutic targets for diseases associated with glutamate dysregulation. Its specificity makes it a useful tool for dissecting the contributions of EAAT1 in comparison to other glutamate transporters in brain function and pathology.